This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Spinal meninges
CD2_BENIGN_MENINGES_SPINAL_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D32
- Name in latin
- Neoplasma benignum meningum spinalium
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Spinal meninges
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Spinal meninges
- Benign neoplasm of meninges
- Benign neoplasm of meninges
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 350 | 248 | 102 |
| Unadjusted period prevalence (%) | 0.07 | 0.08 | 0.04 |
| Median age at first event (years) | 61.81 | 61.88 | 61.64 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 304
- Matched controls
- 3038
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
+∞
323.0
284
*
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
+∞
167.7
145
*
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
104.1
67.5
72
9
9530/0-C70.1
ICD-O-3
Meningioma, NOS, of spinal meninges
+∞
65.0
60
*
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
91.0
48.7
53
7
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
38.4
36.6
46
14
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
10.0
35.7
76
98
H02AB02
ATC
dexamethasone; systemic
34.5
32.6
42
14
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
26.9
32.0
44
19
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
30.7
29
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.5
27.9
123
399
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
26.9
27.8
38
16
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
59.3
27.8
32
6
D33.45
ICD-10 Finland
Benign Schwannom in the nerve root of the spinal cord
295.7
27.2
27
*
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
50.8
27.1
32
7
115
Kela drug reimbursment
Breast cancer
+∞
26.4
25
*
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
135.7
24.0
25
*
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
18.1
23.9
37
23
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
4.3
21.3
92
281
9560/0-C72.0
ICD-O-3
Schwannoma, NOS, of spinal cord
+∞
20.0
19
*
2254A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Spinal meninges
+∞
20.0
19
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
18.9
18
*
NA2DG
NOMESCO Finland
Thoracal spine very extensive MRI examination with high intensity magnet
106.7
18.8
20
*
N03AX16
ATC
pregabalin; oral
3.4
18.6
115
465
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
35.4
18.2
23
7
G82.2
ICD-10 Finland
Paraplegia, unspecified
71.0
17.9
20
*
D33.43
ICD-10 Finland
Spinal cord
+∞
17.9
17
*
D33.4
ICD-10 Finland
Benign neoplasm: Spinal cord
+∞
16.8
16
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
16.8
16
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
16.8
16
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
6.9
16.5
42
69
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
32.1
16.3
21
7
ABB10
NOMESCO Finland
Resection of lesion of spinal canal
+∞
15.8
15
*
N03AX12
ATC
gabapentin; oral
3.4
15.1
82
295
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
+∞
14.7
14
*
2312
FHL
Extirpation or destruction
+∞
14.7
14
*
D32.07
ICD-10 Finland
Secondary or multiple benign tumor of the meninges below the exam
+∞
14.7
14
*
L02BG04
ATC
letrozole; oral
38.1
14.6
18
5
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.3
14.0
81
304
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
13.6
13
*
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
4.1
13.5
55
154
D43.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Spinal cord
73.0
12.7
14
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
12.6
12
*
NA7FT
NOMESCO Finland
Labeling lesion in spinal area with X-ray guidance
+∞
12.6
12
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
12.6
12
*
130
Kela drug reimbursment
Malignant tumour
+∞
12.6
12
*
XKD00
NOMESCO Finland
Uroflowmetry
3.7
12.4
57
177
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
5.3
11.8
36
75
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
31.4
11.8
15
5
WF002
NOMESCO Finland
Radical radiotherapy
+∞
11.5
11
*
A04AA02
ATC
granisetron; systemic, transdermal
124.5
11.5
12
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
124.5
11.5
12
*
N75
ICPC
Benign neoplasm nervous system
124.5
11.5
12
*
A03FA01
ATC
metoclopramide; systemic, rectal
3.3
11.1
60
209
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.0
10.8
44
123
XX3DW
NOMESCO Finland
Time consuming IT work
5.8
10.8
30
56
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.7
10.5
22
27
WX402
NOMESCO Finland
General anaesthesia
3.3
10.5
55
189
L02BA01
ATC
tamoxifen; oral
113.7
10.5
11
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
10.5
10
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
10.5
10
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
10.5
10
*
G992, D321
ICD-10 Finland
NA
+∞
10.5
10
*
M03BX01
ATC
baclofen; systemic
11.2
10.4
19
18
N02AA05
ATC
oxycodone; systemic
3.2
10.0
55
195
HAB40
NOMESCO Finland
Wedge excision of mammary gland
27.0
9.9
13
5
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
27.0
9.9
13
5
R4110
NOMESCO Finland
Physiotherapy
2.4
9.7
94
470
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
56.8
9.7
11
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
56.8
9.7
11
*
XKD06
NOMESCO Finland
Physiologic investigation of micturition
8.0
9.6
21
28
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
+∞
9.4
9
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
9.4
9
*
JN4BD
NOMESCO Finland
Extensive body CT
4.9
9.3
30
67
AA1BD
NOMESCO Finland
Extensive CT of head and brain
10.5
9.1
17
17
M54.2
ICD-10 Finland
Cervicalgia
4.5
9.0
31
74
N02BE01
ATC
paracetamol; systemic, rectal
2.9
9.0
273
2285
WX110
NOMESCO Finland
Local anesthesy
2.1
8.9
208
1530
Z51.5
ICD-10 Finland
Palliative care
10.5
8.6
16
16
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
28.4
8.5
11
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.2
8.5
45
156
N02AX02
ATC
tramadol; systemic, rectal
2.1
8.4
142
901
B01AB10
ATC
tinzaparin; parenteral
5.2
8.4
25
51
9537/0-C70.1
ICD-O-3
Transitional meningioma of spinal meninges
+∞
8.4
8
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
8.4
8
*
D42.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Spinal meninges
+∞
8.4
8
*
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
+∞
8.4
8
*
L01BC06
ATC
capecitabine; oral
+∞
8.4
8
*
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
+∞
8.4
8
*
9531/0-C70.1
ICD-O-3
Meningothelial meningioma of spinal meninges
+∞
8.4
8
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.3
8.2
24
48
UKC02
NOMESCO Finland
Cystoscopy
2.8
8.1
56
229
R20.2
ICD-10 Finland
Paraesthesia of skin
3.6
8.1
36
109
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
22.7
8.1
11
5
N18
ICPC
Paralysis/weakness
8.1
8.0
17
22
N06AX21
ATC
duloxetine; oral
2.9
7.8
48
183
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.6
7.5
25
58
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
82.0
7.4
8
*
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
82.0
7.4
8
*
HA1AA
NOMESCO Finland
X-ray mammography
5.2
7.4
22
45
L28
ICPC
Limited function/disability (L)
2.4
7.4
68
326
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
6.5
7.4
18
29
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
7.3
7
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
7.3
7
*
G82.1
ICD-10 Finland
Spastic paraplegia
+∞
7.3
7
*
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
+∞
7.3
7
*
D33.46
ICD-10 Finland
Benign neurofibroma in the nerve root of the spinal cord
+∞
7.3
7
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
7.3
7
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
7.3
7
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
7.3
7
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
7.3
7
*
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
+∞
7.3
7
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
7.3
7
*
AA1AD
NOMESCO Finland
CT of head and brain
2.1
7.2
91
506
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
30.8
7.2
9
*
TKC20
NOMESCO Finland
Catheterisation of bladder
3.7
7.2
30
87
M48.0
ICD-10 Finland
Spinal stenosis
2.6
7.1
54
234
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.4
7.0
33
105
XKC03
NOMESCO Finland
Water cystometry
4.6
7.0
23
53
A02BC02
ATC
pantoprazole; systemic
1.9
7.0
200
1515
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
6.4
6.9
17
28
N06AA09
ATC
amitriptyline; systemic
2.7
6.8
47
193
S18
ICPC
Laceration/cut
1.9
6.8
130
849
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.6
6.7
22
51
R13
ICD-10 Finland
Dysphagia
3.4
6.7
31
98
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
5.9
6.6
17
30
SPAT1153
SPAT
Removal of sutures
2.0
6.5
104
631
JN4AD
NOMESCO Finland
Body CT examination
4.9
6.5
20
43
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
6.5
85
477
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.4
6.5
30
95
C50
ICD-10 Finland
Malignant neoplasm of breast
71.3
6.4
7
*
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
71.3
6.4
7
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
71.3
6.4
7
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.4
6.4
57
266
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
6.8
6.4
15
23
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
D33.47
ICD-10 Finland
Other benign neurofibromas in the nerve root of the spinal cord
+∞
6.3
6
*
NA1CM
NOMESCO Finland
Cervical spine extensive MRI examination with 3 Tesla magnet
+∞
6.3
6
*
22540
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Spinal meninges
+∞
6.3
6
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
6.3
6
*
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
+∞
6.3
6
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
6.3
6
*
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
+∞
6.3
6
*
L02BG03
ATC
anastrozole; oral
+∞
6.3
6
*
AWW99
NOMESCO Finland
Other reoperation in surgery of the nervous system
+∞
6.3
6
*
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
27.3
6.3
8
*
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
27.3
6.3
8
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.1
6.2
23
60
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
6.2
109
687
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.4
6.1
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
24
15
17.10
28.25
1.8
2.7
—
—
—
0
0
259
1676
3.10
19.69
5.5
3.8
6.5
6.7
mmol/l
1.62
247
1541
84
307
3.28
18.25
5.0
5.5
0.5
1.6
mmol/l
1.62
59
241
122
563
2.79
17.41
2.9
1.8
—
—
—
0
0
198
1176
2.57
16.70
5.1
3.4
—
—
—
0
0
46
119
4.30
16.51
5.0
5.9
23.9
24.8
mmol/l
1.33
46
105
205
1287
2.43
14.64
6.1
4.4
1.2
1.2
mmol/l
0.47
184
1141
14
11
13.22
14.33
2.8
1.1
—
—
—
0
0
19
25
7.98
13.69
2.5
1.2
—
—
—
0
0
217
1426
2.37
13.56
7.2
4.9
1.2
1.2
mmol/l
0.32
186
1221
47
146
3.56
12.99
3.4
1.4
2.5
4.6
ug/l
0.58
38
118
152
940
2.09
10.08
2.5
2.1
220.0
282.9
u/l
0.25
140
882
195
1364
1.97
8.78
7.9
3.4
9.8
11.3
umol/l
2.57
182
1262
25
69
3.82
8.17
1.6
1.4
—
—
—
0
0
10
11
9.33
8.12
2.4
1.5
—
—
—
0
0
174
1193
1.91
8.09
5.6
3.4
34.8
35.5
g/l
0.95
166
1101
121
760
1.90
7.16
3.2
2.9
0.7
0.5
e6/l
0.44
89
549
50
231
2.36
6.61
1.8
1.4
66.4
67.9
g/l
0.72
41
203
143
970
1.80
6.49
3.5
2.0
2.3
2.4
mmol/l
0.44
124
795
201
1508
1.78
6.45
10.1
6.0
4.2
4.2
e9/l
0.14
173
1304
144
984
1.79
6.34
3.8
3.0
—
—
—
0
0
16
41
4.04
5.78
1.8
1.4
—
—
—
0
0
81
477
1.91
5.67
2.4
2.5
1.2
1.3
e6/l
0.03
49
248
38
168
2.42
5.54
1.8
1.6
—
—
—
0
0
63
345
2.01
5.43
5.0
3.8
1.0
1.0
mmol/l
0.24
57
309
67
376
1.97
5.39
2.4
2.0
0.8
0.8
mmol/l
0.56
58
348
29
115
2.66
5.28
1.3
1.3
7.4
7.7
g/l
0.18
19
83
29
115
2.66
5.28
1.3
1.3
3.5
3.9
g/l
0.75
18
82
29
115
2.66
5.28
1.3
1.3
—
—
—
0
0
258
2145
1.77
5.21
10.5
5.1
78.9
75.8
u/l
0.75
248
1964
73
432
1.87
5.00
2.6
2.8
2.0
3.1
e6/l
0.74
40
203
15
41
3.78
4.98
1.4
1.3
—
—
—
0
0
120
824
1.69
4.94
3.3
2.5
30.1
32.5
u/l
0.32
109
784
24
90
2.79
4.86
1.3
1.2
37.1
38.0
g/l
0.19
17
73
27
108
2.63
4.84
1.3
1.3
3.1
3.0
g/l
0.13
18
84
41
199
2.20
4.83
2.0
1.8
0.2
0.2
g/l
0.16
34
181
24
91
2.76
4.76
1.5
1.2
0.6
0.4
g/l
0.21
17
77
27
109
2.60
4.75
1.3
1.2
9.1
10.7
g/l
1.88
20
90
12
29
4.25
4.66
1.3
1.1
—
—
—
0
0
49
259
2.04
4.64
3.9
2.2
5.0
6.5
umol/l
1.69
43
215
12
30
4.11
4.47
1.3
1.1
—
—
—
0
0
12
30
4.11
4.47
1.3
1.1
—
—
—
0
0
17
56
3.14
4.30
1.2
1.2
—
—
—
0
0
12
31
3.97
4.29
1.3
1.1
—
—
—
0
0
12
31
3.97
4.29
1.3
1.1
—
—
—
0
0
12
31
3.97
4.29
1.3
1.1
—
—
—
0
0
123
880
1.61
4.20
3.6
2.0
54.3
55.7
u/l
0.19
113
797
314
2839
2.03
4.04
22.4
12.2
21.1
22.3
mg/l
0.33
283
2162
23
94
2.55
3.97
1.7
1.8
—
—
—
0
0
68
423
1.75
3.91
2.3
1.8
—
—
—
0
0
11
30
3.75
3.66
1.2
1.2
—
—
—
0
0
256
2214
1.58
3.53
4.9
4.2
13.9
12.7
mm/h
0.49
240
2010
100
709
1.57
3.45
2.7
2.2
3.4
3.1
mg/l
0.67
86
593
18
70
2.66
3.44
1.9
1.2
1434.2
253.8
e6/l
0.61
11
60
18
70
2.66
3.44
1.8
1.1
67.5
15.0
e6/l
0.44
11
59
65
414
1.70
3.43
2.7
2.2
11.3
13.5
umol/l
1.36
58
375
11
32
3.52
3.36
1.4
1.1
—
—
—
0
0
90
627
1.59
3.34
2.0
1.7
1149.3
1218.4
nmol/l
0.31
66
456
21
90
2.42
3.31
1.8
1.7
—
—
—
0
0
157
1236
1.49
3.31
2.4
2.3
77.8
79.8
nmol/l
0.50
140
1073
84
577
1.60
3.30
3.2
2.2
2.5
2.4
mmol/l
0.64
76
491
20
85
2.43
3.21
1.4
1.2
0.0
0.1
g/l
0.49
15
76
46
271
1.80
3.17
4.1
3.0
—
—
—
0
0
41
237
1.83
3.01
2.1
2.0
28.5
32.2
u/l
0.42
35
189
208
1755
1.46
2.95
4.4
2.8
46.2
43.7
u/l
0.27
195
1610
53
333
1.70
2.94
2.8
2.4
21.8
23.9
%
0.37
45
284
62
407
1.64
2.91
7.1
7.2
—
—
—
0
0
18
77
2.41
2.87
1.3
1.1
0.0
0.0
g/l
0.00
13
70
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
14
5.08
2.74
1.1
1.1
—
—
—
0
0
18
79
2.35
2.72
1.3
1.1
0.0
0.0
g/l
0.00
13
71
11
37
3.04
2.71
1.5
1.8
89.2
90.5
%
0.31
11
37
6
10
6.08
2.71
1.2
1.5
—
—
—
0
0
30
165
1.89
2.58
1.4
1.4
—
—
—
0
0
55
363
1.61
2.53
2.7
2.3
2.3
2.3
g/l
0.20
50
337
297
2725
1.59
2.53
18.8
11.3
78.9
76.0
ml/min/173m2
1.48
269
2140
9
26
3.52
2.50
2.2
1.4
—
377.4
—
0
5
47
303
1.64
2.38
2.5
1.8
—
—
—
0
0
8
22
3.70
2.37
1.9
1.9
—
—
—
0
0
27
149
1.88
2.32
1.7
1.7
—
—
—
0
0
145
1188
1.38
2.22
4.0
3.6
53.1
63.4
ng/l
0.11
111
854
14
62
2.31
2.10
1.6
1.4
31.4
26.8
iu/l
0.15
14
56
173
1470
1.35
2.06
4.8
3.8
0.0
0.0
estimate
0.50
31
238
6
15
4.05
2.04
1.2
1.1
—
—
—
0
0
27
157
1.78
1.99
3.8
3.8
3.4
2.0
mmol/l
1.10
21
117
145
1208
1.34
1.94
3.3
2.7
153.6
111.0
ug/l
0.73
134
1104
7
22
3.22
1.89
1.6
1.0
—
—
—
0
0
7
22
3.22
1.89
1.3
1.4
—
—
—
0
0
6
17
3.57
1.84
1.0
1.4
—
—
—
0
0
156
1322
1.32
1.83
2.2
2.0
94.5
95.7
pmol/l
0.10
82
642
23
132
1.79
1.78
1.7
2.7
0.3
0.2
e6/l
0.26
23
127
96
760
1.36
1.77
1.5
1.5
21.4
21.6
nmol/l
0.04
76
655
44
304
1.51
1.69
2.6
1.8
—
—
—
0
0
168
1450
1.31
1.69
5.9
5.1
0.0
0.0
estimate
0.00
33
241
80
622
1.37
1.64
2.0
1.6
1.0
1.0
mg/l
0.02
64
479
6
20
3.03
1.58
1.7
1.1
—
—
—
0
0
7
27
2.62
1.52
1.0
1.0
—
—
—
0
0
40
280
1.48
1.46
4.5
2.7
5.7
5.8
kpa
0.48
40
272
165
1447
1.27
1.38
4.7
3.8
0.0
0.0
estimate
0.00
30
245
291
2751
1.34
1.26
5.6
4.9
1.9
2.4
mu/l
0.46
264
2479
8
36
2.25
1.25
1.5
1.4
—
—
—
0
0
6
25
2.42
1.25
1.0
1.2
—
—
—
0
0
8
37
2.19
1.22
1.3
1.1
—
—
—
0
0
6
26
2.33
1.19
1.2
1.1
—
1.2
—
0
11
72
581
1.30
1.16
4.6
3.8
135.0
199.2
ng/l
0.20
59
456
52
400
1.35
1.16
5.0
5.0
35.0
32.7
%
0.70
33
252
10
51
1.99
1.12
1.8
1.4
—
—
—
0
0
76
621
1.29
1.11
5.3
3.9
2.8
2.1
ug/l
0.83
67
552
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
66
1.85
1.10
1.9
2.6
0.2
0.4
u/ml
—
7
37
34
246
1.42
1.08
2.1
2.0
53.6
63.6
ml/min/173m2
0.66
11
97
7
32
2.21
1.08
1.6
1.1
—
—
—
0
0
13
74
1.79
1.08
1.2
1.1
—
—
—
0
0
66
532
1.30
1.07
1.4
1.3
20.2
38.7
iu/ml
1.42
22
167
12
67
1.82
1.06
1.4
1.4
—
—
—
0
0
5
22
2.29
1.03
1.6
1.6
—
—
—
0
0
7
34
2.08
1.03
1.6
1.1
—
—
—
0
0
9
47
1.94
1.03
1.9
1.4
—
—
—
0
0
171
1547
1.21
0.97
2.5
2.6
—
—
—
0
0
82
688
1.25
0.97
2.0
1.8
483.0
26297409.9
pmol/l
1.06
65
559
9
51
1.78
0.95
3.2
1.3
—
—
—
0
0
9
51
1.78
0.95
3.2
1.3
—
—
—
0
0
6
28
2.16
0.92
1.5
1.0
—
—
—
0
0
91
779
1.23
0.90
5.7
4.1
0.0
0.0
estimate
0.00
33
239
11
64
1.74
0.87
1.4
2.4
1.1
1.5
mg/l
1.83
11
57
8
45
1.80
0.85
1.0
1.3
—
—
—
0
0
6
33
1.83
0.79
2.5
3.4
—
—
—
0
0
6
33
1.83
0.79
2.0
1.5
—
—
—
0
0
49
397
1.27
0.79
31.7
25.8
1.5
1.3
inr
0.52
11
54
318
3091
1.31
0.74
14.1
8.9
25.7
24.5
u/l
0.24
310
2948
7
38
1.86
0.74
1.0
1.2
—
—
—
0
0
12
77
1.58
0.69
2.4
3.5
—
—
—
0
0
7
42
1.68
0.69
1.3
1.2
34.2
19.7
u/l
—
7
35
74
639
1.20
0.68
1.3
1.2
0.6
1.8
u/ml
1.49
16
164
244
2320
1.17
0.67
4.8
4.0
15.1
14.9
pmol/l
0.52
219
2089
5
28
1.80
0.66
1.4
1.4
—
—
—
0
0
11
70
1.59
0.66
1.0
1.2
—
—
—
0
0
288
2778
1.21
0.65
6.5
6.3
39.5
40.3
mmol/mol
0.77
259
2559
42
343
1.26
0.65
2.9
2.7
1.2
0.8
ug/l
0.38
27
228
281
2903
0.84
0.62
5.0
4.7
1.5
1.5
mmol/l
0.13
251
2640
8
50
1.61
0.61
2.0
1.3
1.5
0.6
nmol/l
—
8
44
10
64
1.58
0.59
1.4
1.7
—
—
—
0
0
6
35
1.73
0.58
2.0
1.5
—
—
—
0
0
5
90
0.55
0.56
1.2
1.4
—
—
—
0
0
10
65
1.55
0.56
1.0
1.1
—
17.3
—
0
6
106
961
1.15
0.54
3.3
2.8
1597.2
1292.3
ng/l
0.31
96
815
9
62
1.46
0.53
1.3
1.2
—
—
—
0
0
57
494
1.18
0.52
4.4
3.7
21.7
24.9
%
0.82
26
238
6
40
1.51
0.52
1.2
1.1
—
—
—
0
0
6
40
1.51
0.52
2.0
1.4
—
—
—
0
0
34
281
1.23
0.50
3.0
2.4
3.8
5.4
ug/l
0.97
29
242
28
229
1.24
0.45
4.5
2.2
4.5
4.5
kpa
0.10
28
222
5
33
1.52
0.41
1.6
1.4
—
—
—
0
0
5
33
1.52
0.41
1.2
1.2
10.9
7.5
mmol/l
—
5
19
110
1020
1.11
0.39
3.7
3.9
14.4
5.9
mg/mmol
0.59
67
614
286
2925
0.88
0.38
5.0
4.7
4.6
4.7
mmol/l
0.36
258
2670
16
202
0.78
0.38
1.5
1.7
—
—
—
0
0
6
42
1.44
0.35
1.8
1.3
—
—
—
0
0
6
43
1.40
0.35
3.3
1.3
—
—
—
0
0
6
45
1.34
0.34
2.0
1.4
—
—
—
0
0
294
2993
0.89
0.31
5.5
5.4
2.7
2.7
mmol/l
0.12
264
2725
262
2556
1.10
0.30
23.2
13.5
38.1
39.5
%
1.38
178
1677
90
840
1.10
0.29
1.7
1.7
1.4
1.3
mmol/l
0.49
80
709
274
2794
0.91
0.27
4.4
4.2
1.3
1.3
mmol/l
0.07
241
2510
13
159
0.81
0.25
4.3
2.0
1.2
1.2
%
0.04
13
159
9
76
1.19
0.25
1.8
1.4
—
—
—
0
0
16
189
0.84
0.23
1.3
1.1
114.0
135.3
iu/ml
—
6
77
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
64
680
0.93
0.18
5.5
4.3
1.0
1.0
kg/l
0.41
11
97
5
66
0.75
0.17
2.2
1.8
—
—
—
0
0
8
72
1.11
0.16
1.4
1.2
—
32.7
—
0
9
6
79
0.76
0.15
2.3
1.9
—
—
—
0
0
49
521
0.93
0.15
1.3
1.3
2.4
14.0
u/ml
2.70
21
188
7
88
0.79
0.14
1.6
1.7
—
—
—
0
0
12
139
0.86
0.14
1.1
1.0
—
—
—
0
0
13
149
0.87
0.14
1.5
1.3
—
—
—
0
0
75
721
1.05
0.11
3.4
2.3
332.5
7535.0
umol/l
3.63
67
608
115
1119
1.04
0.11
5.6
4.0
—
—
—
0
0
11
96
1.15
0.10
1.5
1.2
—
2.8
—
0
5
6
58
1.04
0.08
1.0
1.3
—
228.8
—
0
27
13
117
1.12
0.08
1.8
2.2
—
—
—
0
0
9
104
0.86
0.06
1.6
1.2
—
—
—
0
0
9
104
0.86
0.06
1.6
1.2
—
—
—
0
0
40
413
0.96
0.04
1.5
1.5
—
—
—
0
0
294
2928
1.03
0.03
5.2
4.8
5.9
6.0
mmol/l
0.49
264
2640
16
158
1.01
0.00
1.4
1.9
—
—
—
0
0
46
457
1.01
0.00
1.5
1.4
—
—
—
0
0
18
175
1.03
0.00
1.6
2.1
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
114.4
—
0
5
7
79
0.88
0.00
1.4
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
116.0
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
5
51
0.98
0.00
1.2
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
3.2
—
75.5
—
0
6
8
87
0.92
0.00
2.4
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
6
62
0.97
0.00
1.0
1.1
1.1
0.9
nmol/l
—
6
46
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_MENINGES_SPINAL_EXALLC – Benign neoplasm: Spinal meninges
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).